Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Nov;60(Suppl 3):iii71–iii74. doi: 10.1136/ard.60.90003.iii71

Antagonising angiogenesis in rheumatoid arthritis

P Brenchley
PMCID: PMC1766681  PMID: 11890660

Full Text

The Full Text of this article is available as a PDF (94.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berse B., Hunt J. A., Diegel R. J., Morganelli P., Yeo K., Brown F., Fava R. A. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol. 1999 Jan;115(1):176–182. doi: 10.1046/j.1365-2249.1999.00775.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bottomley M. J., Webb N. J., Watson C. J., Holt P. J., Freemont A. J., Brenchley P. E. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol. 1999 Jul;117(1):171–176. doi: 10.1046/j.1365-2249.1999.00949.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burgess W. H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 1989;58:575–606. doi: 10.1146/annurev.bi.58.070189.003043. [DOI] [PubMed] [Google Scholar]
  4. Clark B. R., Gallagher J. T., Dexter T. M. Cell adhesion in the stromal regulation of haemopoiesis. Baillieres Clin Haematol. 1992 Jul;5(3):619–652. doi: 10.1016/s0950-3536(11)80010-7. [DOI] [PubMed] [Google Scholar]
  5. Dinbergs I. D., Brown L., Edelman E. R. Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem. 1996 Nov 22;271(47):29822–29829. doi: 10.1074/jbc.271.47.29822. [DOI] [PubMed] [Google Scholar]
  6. Dodge G. R., Boesler E. W., Jimenez S. A. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells. Lab Invest. 1995 Nov;73(5):649–657. [PubMed] [Google Scholar]
  7. Faham S., Linhardt R. J., Rees D. C. Diversity does make a difference: fibroblast growth factor-heparin interactions. Curr Opin Struct Biol. 1998 Oct;8(5):578–586. doi: 10.1016/s0959-440x(98)80147-4. [DOI] [PubMed] [Google Scholar]
  8. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934. [PubMed] [Google Scholar]
  9. Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D., Semenza G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996 Sep;16(9):4604–4613. doi: 10.1128/mcb.16.9.4604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gitay-Goren H., Soker S., Vlodavsky I., Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem. 1992 Mar 25;267(9):6093–6098. [PubMed] [Google Scholar]
  11. Hulett M. D., Freeman C., Hamdorf B. J., Baker R. T., Harris M. J., Parish C. R. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med. 1999 Jul;5(7):803–809. doi: 10.1038/10525. [DOI] [PubMed] [Google Scholar]
  12. Jackson J. R., Minton J. A., Ho M. L., Wei N., Winkler J. D. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J Rheumatol. 1997 Jul;24(7):1253–1259. [PubMed] [Google Scholar]
  13. Koch A. E., Halloran M. M., Hosaka S., Shah M. R., Haskell C. J., Baker S. K., Panos R. J., Haines G. K., Bennett G. L., Pope R. M. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum. 1996 Sep;39(9):1566–1575. doi: 10.1002/art.1780390917. [DOI] [PubMed] [Google Scholar]
  14. Koch A. E., Harlow L. A., Haines G. K., Amento E. P., Unemori E. N., Wong W. L., Pope R. M., Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994 Apr 15;152(8):4149–4156. [PubMed] [Google Scholar]
  15. Koch A. E. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998 Jun;41(6):951–962. doi: 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  16. Kussie P. H., Hulmes J. D., Ludwig D. L., Patel S., Navarro E. C., Seddon A. P., Giorgio N. A., Bohlen P. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun. 1999 Jul 22;261(1):183–187. doi: 10.1006/bbrc.1999.0962. [DOI] [PubMed] [Google Scholar]
  17. Levick J. R. Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol. 1990 May;17(5):579–582. [PubMed] [Google Scholar]
  18. Levy N. S., Goldberg M. A., Levy A. P. Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim Biophys Acta. 1997 May 30;1352(2):167–173. doi: 10.1016/s0167-4781(97)00052-3. [DOI] [PubMed] [Google Scholar]
  19. Li J., Perrella M. A., Tsai J. C., Yet S. F., Hsieh C. M., Yoshizumi M., Patterson C., Endege W. O., Zhou F., Lee M. E. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem. 1995 Jan 6;270(1):308–312. doi: 10.1074/jbc.270.1.308. [DOI] [PubMed] [Google Scholar]
  20. Miotla J., Maciewicz R., Kendrew J., Feldmann M., Paleolog E. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest. 2000 Aug;80(8):1195–1205. doi: 10.1038/labinvest.3780127. [DOI] [PubMed] [Google Scholar]
  21. Moscatelli D. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol. 1988 Aug;107(2):753–759. doi: 10.1083/jcb.107.2.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oliver S. J., Banquerigo M. L., Brahn E. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Immunol. 1994 Aug;157(1):291–299. doi: 10.1006/cimm.1994.1223. [DOI] [PubMed] [Google Scholar]
  23. Oliver S. J., Cheng T. P., Banquerigo M. L., Brahn E. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). Cell Immunol. 1995 Dec;166(2):196–206. doi: 10.1006/cimm.1995.9978. [DOI] [PubMed] [Google Scholar]
  24. Park J. E., Keller G. A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell. 1993 Dec;4(12):1317–1326. doi: 10.1091/mbc.4.12.1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Peacock D. J., Banquerigo M. L., Brahn E. Angiogenesis inhibition suppresses collagen arthritis. J Exp Med. 1992 Apr 1;175(4):1135–1138. doi: 10.1084/jem.175.4.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem. 1994 Mar 4;269(9):6271–6274. [PubMed] [Google Scholar]
  27. Qu Z., Huang X. N., Ahmadi P., Andresevic J., Planck S. R., Hart C. E., Rosenbaum J. T. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest. 1995 Sep;73(3):339–346. [PubMed] [Google Scholar]
  28. Sano H., Forough R., Maier J. A., Case J. P., Jackson A., Engleka K., Maciag T., Wilder R. L. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol. 1990 Apr;110(4):1417–1426. doi: 10.1083/jcb.110.4.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Semble E. L., Turner R. A., McCrickard E. L. Rheumatoid arthritis and osteoarthritis synovial fluid effects on primary human endothelial cell cultures. J Rheumatol. 1985 Apr;12(2):237–241. [PubMed] [Google Scholar]
  30. Semenza G. L., Nejfelt M. K., Chi S. M., Antonarakis S. E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5680–5684. doi: 10.1073/pnas.88.13.5680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sewell R. F., Brenchley P. E., Mallick N. P. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate. Biochem J. 1989 Dec 15;264(3):777–783. doi: 10.1042/bj2640777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  33. Sone H., Kawakami Y., Sakauchi M., Nakamura Y., Takahashi A., Shimano H., Okuda Y., Segawa T., Suzuki H., Yamada N. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun. 2001 Feb 23;281(2):562–568. doi: 10.1006/bbrc.2001.4395. [DOI] [PubMed] [Google Scholar]
  34. Stavri G. T., Zachary I. C., Baskerville P. A., Martin J. F., Erusalimsky J. D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation. 1995 Jul 1;92(1):11–14. doi: 10.1161/01.cir.92.1.11. [DOI] [PubMed] [Google Scholar]
  35. Stevens C. R., Blake D. R., Merry P., Revell P. A., Levick J. R. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum. 1991 Dec;34(12):1508–1513. doi: 10.1002/art.1780341206. [DOI] [PubMed] [Google Scholar]
  36. Storgard C. M., Stupack D. G., Jonczyk A., Goodman S. L., Fox R. I., Cheresh D. A. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest. 1999 Jan;103(1):47–54. doi: 10.1172/JCI3756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Szekanecz Z., Koch A. E., Kunkel S. L., Strieter R. M. Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging. 1998 May;12(5):377–390. doi: 10.2165/00002512-199812050-00004. [DOI] [PubMed] [Google Scholar]
  38. Tanaka Y., Fujii K., Hübscher S., Aso M., Takazawa A., Saito K., Ota T., Eto S. Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis. Arthritis Rheum. 1998 Aug;41(8):1365–1377. doi: 10.1002/1529-0131(199808)41:8<1365::AID-ART5>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  39. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., Bitan M., Pappo O., Peretz T., Michal I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999 Jul;5(7):793–802. doi: 10.1038/10518. [DOI] [PubMed] [Google Scholar]
  40. Vlodavsky I., Korner G., Ishai-Michaeli R., Bashkin P., Bar-Shavit R., Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 1990 Nov;9(3):203–226. doi: 10.1007/BF00046361. [DOI] [PubMed] [Google Scholar]
  41. Walsh D. A., Wade M., Mapp P. I., Blake D. R. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol. 1998 Mar;152(3):691–702. [PMC free article] [PubMed] [Google Scholar]
  42. Watson C. J., Webb N. J., Bottomley M. J., Brenchley P. E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000 Aug;12(8):1232–1235. doi: 10.1006/cyto.2000.0692. [DOI] [PubMed] [Google Scholar]
  43. Wiseman D. M., Polverini P. J., Kamp D. W., Leibovich S. J. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun. 1988 Dec 15;157(2):793–800. doi: 10.1016/s0006-291x(88)80319-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES